Transcription of GLOBAL TUBERCULOSIS REPORT 2017 - WHO
{{id}} {{{paragraph}}}
Example: bankruptcy
GLOBAL TUBERCULOSIS REPORT 2017 - WHO
GLOBAL . TUBERCULOSIS . REPORT . 2017 . Abbreviations aDSM active TB drug-safety monitoring and NCD noncommunicable disease management NFC near-field communication AIDS acquired immunodeficiency syndrome NHI national health insurance ART antiretroviral therapy NTP national TB programme BCG bacille Calmette-Gu rin OECD Organisation for Economic Co-operation and BRICS Brazil, Russian Federation, India, China and Development South Africa OIE World Organisation for Animal Health CFR case fatality ratio OOP out-of-pocket CHOICE CHOosing Interventions that are Cost-Effective PEPFAR President's Emergency Plan For AIDS Relief (WHO). PMDT programmatic management of drug- resistant CI confidence interval TB. CRS creditor reporting system P:N prevalence to notification (ratio). DST drug susceptibility testing PPM public-public and public-private mix EBA early bactericidal activity RR-TB rifampicin- resistant TB.
Treatment success rates of at least 85% for cases of drug-susceptible TB are regularly reported to WHO by its 194 Member States. Treatment for rifampicin-resistant TB (RR-TB) and multidrug-resistant TB (MDR-TB)b is longer, and requires more expensive and more toxic drugs. Until early 2016, the treatment regimens recommended
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: